Intrinsiqs

Is LeMaitre Vascular, Inc. overvalued?

LeMaitre Vascular, Inc. (LMAT) looks undervalued — trading about 30% below its fair value.

Undervalued
Current price $78.29 Fair value $101.52
Price
$78.29
Fair value
$101.52
Current P/E
30.3
Normal P/E
39.4
Market cap
$1.79B
Dividend yield
1.2%
Return on equity
15.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares LMAT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.